-
1
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
Published 2025-01-01“…Finally, it summarizes gaps in knowledge, discusses future directions, and highlights recent advances and state-of-the-art research presented at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand.…”
Get full text
Article -
2
Transfusion in trauma: empiric or guided therapy?
Published 2025-01-01“…Empiric vs guided” was presented at the International Society on Thrombosis and Haemostasis Congress in 2024. Uncontrolled bleeding is the commonest preventable cause of death after traumatic injury. …”
Get full text
Article -
3
Structural bioinformatics for rational drug design
Published 2025-01-01“…A State of the Art lecture titled “structural bioinformatics technologies for rational drug design: from in silico to in vivo” was presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in 2024. …”
Get full text
Article -
4
Translation and Cultural Adaptation of the ISTH-Bleeding Assessment Tool to European Portuguese
Published 2025-02-01“…The International Society on Thrombosis and Haemostasis-Bleeding Assessment Tool (ISTH-BAT) is a standardized bleeding assessment tool used during the diagnostic workup of suspected bleeding disorders. …”
Get full text
Article -
5
Assessment of Bleeding Risks and Patient Knowledge Levels About Bleeding Disorders in Patients Referred to the Oral and Maxillofacial Surgery Clinic
Published 2024-01-01“…Objective: The objective of this study was to examine patients’ awareness of bleeding disorders in dental clinics and to identify patients with bleeding disorders using the International Society on Thrombosis and Haemostasis-Bleeding Assessment Tools (ISTH-BAT bleeding score before dental surgery. …”
Get full text
Article -
6
Prevalence and clinical impact of disseminated intravascular coagulation in acute aortic dissection: a nationwide cohort study
Published 2025-01-01“…DIC was diagnosed based on the criteria of the Japanese Association for Acute Medicine (JAAM-2) and the International Society on Thrombosis and Haemostasis (ISTH). We compared the in-hospital mortality between patients with and without DIC and assessed the impact of coagulopathy using various coagulation profiles. …”
Get full text
Article -
7
Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart...
Published 2020-09-01“…The primary safety endpoint is major bleeding, according to the International Society on Thrombosis and Haemostasis bleeding criteria.Ethics and dissemination The study protocol has been approved by the institutional review board/independent ethics committee at each site prior to study commencement. …”
Get full text
Article -
8
Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps
Published 2025-01-01“…This manuscript follows literature reviews and structured discussions by the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Working Group on Gene Therapy that identified specific areas requiring standardization of methods, including viral vector production, liver function assessment, quantification of factor (F)VIII and FIX expression levels, assessment of antiadeno-associated viral antibodies, and genomic integration detection methods. …”
Get full text
Article -
9
Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis
Published 2020-09-01“…We aimed to compare the efficacy and safety of DAT regimens using a network meta-analysis (NMA) approach.Design A systematic review and NMA of randomised clinical trials.Methods We conducted a systematic literature review to identify relevant randomised clinical trials and performed a Bayesian NMA for International Society on Thrombosis and Haemostasis (ISTH) major or clinically relevant non-major (CRNM) bleeding, all-cause mortality, stroke, myocardial infarction (MI) and stent thrombosis outcomes. …”
Get full text
Article